Accelerating Innovation and Market Exclusivity Through Regulatory Incentives

About this session

How will the GPL and the Biotech Act create additional incentives for market access? Implications of initiatives on regulatory data protection and market exclusivity Navigating changes to Supplementary Protection Certificates (SPCs) and their impact on market exclusivity Regulatory strategies to maximise available incentives Comparing key global differences in approaches to incentives

Speakers

• 

  Rebecca Lumsden

  Head of Regulatory Science & Policy, Europe · Sanofi

  Moderator

• 

  Rainer Becker

  Director, DG Health & Food Safety · European Commission

  Panelist

• 

  Ann Lindberg

  Director General · Swedish Medical Products Agency

  Panelist

• 

  Hugh Pullen

  Chair, EuropaBio Healthcare Council and VP, Head of Public Affairs Region Europe · Novartis

  Panelist